| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JSO.2930390302 |
| P698 | PubMed publication ID | 3184950 |
| P2093 | author name string | Seigler HF | |
| Slingluff CL Jr | |||
| Vollmer R | |||
| P433 | issue | 3 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 139-147 | |
| P577 | publication date | 1988-11-01 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients | |
| P478 | volume | 39 |
| Q44869575 | A new American Joint Committee on Cancer staging system for cutaneous melanoma |
| Q77366769 | Classification and staging of melanoma |
| Q33792411 | Combined inguinal and pelvic lymph node dissection for stage III melanoma |
| Q50147643 | Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside |
| Q40987316 | Favorable prognostic factors in recurrent and metastatic melanoma |
| Q74012235 | Judging the therapeutic value of lymph node dissections for melanoma |
| Q34659721 | Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis |
| Q34964449 | Prognostic factors |
| Q68060950 | Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis |
| Q33588526 | Prospects for the therapeutic use of anticancer vaccines |
| Q74552332 | Role of elective lymph node dissection in melanoma |
| Q38646103 | Surgical Management of Melanoma |
| Q41207360 | Surgical management of stage I and II melanoma patients: approach to the regional lymph node basin |
| Q36639818 | Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma |
Search more.